2-(Benzyloxy)-4-chloro-3-nitropyridine → 2-Benzyloxy-4-(2-chloro-4-methoxy-5-methyl-phenyl)-3-nitro-pyridine

HRID 1831581노트

반응식

HRID 1831581 반응식
[CH2:1]([O:8][C:9]1[C:14]([N+:15]([O-:17])=[O:16])=[C:13](Cl)[CH:12]=[CH:11][N:10]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[Cl:19][C:20]1[CH:25]=[C:24]([O:26][CH3:27])[C:23]([CH3:28])=[CH:22][C:21]=1B(O)O>>[CH2:1]([O:8][C:9]1[C:14]([N+:15]([O-:17])=[O:16])=[C:13]([C:21]2[CH:22]=[C:23]([CH3:28])[C:24]([O:26][CH3:27])=[CH:25][C:20]=2[Cl:19])[CH:12]=[CH:11][N:10]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1

참가 물질

3

반응물 2

HCID 220520652-(Benzyloxy)-4-chloro-3-nitropyridineHCID 22052179(2-Chloro-4-methoxy-5-methylphenyl)boronic acid

생성물 1

HCID 220520442-Benzyloxy-4-(2-chloro-4-methoxy-5-methyl-phenyl)-3-nitro-pyridine수율 39%

실험 절차

2-Benzyloxy-4-chloro-3-nitro-pyridine (Wilde, et. al. WO 99/01454) (924 mg, 3.49 mmol) and 2-chloro-5-methyl-4-methoxyphenylboronic acid (prepared substantially as described in Speicher, A.; Kolz, J.; Sambanje, R. P. Synthesis, 2002, 17, 2503) (770 mg, 3.84 mmol) were treated substantially as described in Part A of Example 19a to give 514 mg (39%) of 2-benzyloxy-4-(2-chloro-4-methoxy-5-methyl-phenyl)-3-nitro-pyridine: 1H NMR (400 MHz, CDCl3) δ ppm 8.27 (d, J=5.4 Hz, 1 H), 7.47–7.44 (m, 2H), 7.40–7.30 (m, 3H), 7.00 (s, 1H), 6.94 (d, J=5.4 Hz, 1 H), 6.90 (s, 1 H), 5.55 (s, 2 H), 3.84 (s, 3 H), 2.17 (s, 3 H).

후처리

  1. customSynthesis, 2002, 17, 2503) (770 mg, 3.84 mmol)
  2. additionwere treated substantially

출처 및 근거

ORD 기록
ord-6534e6c654c840fb8e81a608311bd8fd
출처 데이터셋
uspto-grants-2006_06
특허 번호
US07067658B2

반응 노트

불러오는 중…